Arthur F Ryan Net Worth & Insider Trades
Arthur F Ryan - Director, Regeneron Pharmaceuticals, Inc
What is Arthur F Ryan's Net Worth?
The current estimated net worth of Regeneron Pharmaceuticals, Inc's Director, Arthur F Ryan, is estimated to be about $84.47M . Arthur F Ryan owns about 19,147 units of Regeneron Pharmaceuticals, Inc common stock. In the last 19 years at Regeneron Pharmaceuticals, Inc, Arthur F Ryan has sold an estimated value of $60.75M worth.
What is Arthur F Ryan's Past Insider Trading?
Arthur F Ryan's largest purchase order was 50,124 units , worth over $18.73M on May 7, 2020. Arthur F Ryan's largest sale order was 50,124 units , worth over $27.61M on May 7, 2020. In total, Arthur F Ryan has made about 59 transactions over 19 years of their time at Regeneron Pharmaceuticals, Inc. Arthur F Ryan usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 100 units , worth over $76.25K on March 3, 2023.
Arthur F Ryan
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Arthur F Ryan's' Mailing Address?
- Mailing address is Citizens Financial Group, Inc 600 Washington Boulevard Stamford CT 06901 CT
Regeneron Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Leonard S. Schleifer, M.D., Ph.D. | 2020 | $1,480,119 | $130,000,032 | $3,567,714 | $3,567,714 | $302,256 | $135,350,121 |
| Leonard S. Schleifer, M.D., Ph.D. | 2019 | $1,377,100 | $4,983,226 | $3,057,162 | $3,057,162 | $338,043 | $21,455,117 |
| Leonard S. Schleifer, M.D., Ph.D. | 2018 | $1,330,500 | - | $2,953,710 | $2,953,710 | $896,432 | $26,520,555 |
| George D. Yancopoulos, M.D., Ph.D. | 2020 | $1,258,096 | $130,000,032 | $3,004,391 | $3,004,391 | $120,800 | $134,383,319 |
| George D. Yancopoulos, M.D., Ph.D. | 2019 | $1,170,500 | $4,983,226 | $2,598,510 | $2,598,510 | $212,313 | $20,664,135 |
| George D. Yancopoulos, M.D., Ph.D. | 2018 | $1,130,900 | - | $2,510,598 | $2,510,598 | $399,718 | $25,381,129 |
| Robert E. Landry | 2020 | $825,577 | $949,560 | $938,872 | $938,872 | $24,195 | $6,197,703 |
| Robert E. Landry | 2019 | $730,000 | $2,840,008 | $811,395 | $811,395 | $23,470 | $7,931,542 |
| Robert E. Landry | 2018 | $680,000 | $4,767,500 | $581,400 | $581,400 | $19,535 | $9,356,619 |
| Daniel P. Van Plew | 2020 | $825,577 | $3,409,560 | $938,872 | $938,872 | $20,945 | $8,654,453 |
| Daniel P. Van Plew | 2019 | $683,100 | $2,840,008 | $759,266 | $759,266 | $20,470 | $7,829,513 |
| Daniel P. Van Plew | 2018 | $660,000 | - | $677,160 | $677,160 | $19,915 | $9,007,222 |
| Andrew J. Murphy, Ph.D. | 2020 | $726,923 | $5,025,288 | $887,250 | $887,250 | $24,195 | $10,998,914 |
| Andrew J. Murphy, Ph.D. | 2019 | $600,000 | $4,702,308 | $666,900 | $666,900 | $23,470 | $9,519,347 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm
What are Regeneron Pharmaceuticals, Inc's Past Insider Trades?
Regeneron Pharmaceuticals, Inc's most recent insider trade came on March 3, 2023 by Arthur F Ryan who sold 100 units worth $76.25K . In the last 20 years, insiders at Regeneron Pharmaceuticals, Inc have sold an estimated value of $17.54B and bought an estimated value of $3.54B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director, Michael S Brown, Director, and P. Roy Vagelos, Director .
REGENERON PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||